Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Evolution and Performance Drivers Management is transitioning the platform from reactive specialty care to a proactive, data-driven longevity model centered on diagnostics and personalized interventions. Performance was driven by a 65% adoption rate of personalized treatments among 2.5 million subscribers, which increased monthly revenue per subscriber by 11% year-over-year. The weight loss offering reached a $100 million revenue run rate in less than seven months, excluding compounded GLP-1s, demonstrating strong demand for non-injectable metabolic treatments. Strategic verticalization through $300 million in facility investments has enabled the company to lower costs and deliver custom pharmaceutical-supplement formulas at scale. The acquisition of Eucalyptus is intended to establish category leadership in Australia and Japan, positioning the international segment to reach $1 billion in annual reven
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of InvestorsBusiness Wire
- Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of InvestorsBusiness Wire
- Hims Faces GLP-1 Scrutiny While Broader Telehealth Growth Story Evolving [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health (HIMS) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- 2/25/26 - Form 4
- HIMS's page on the SEC website